Annual EBITDA
-$205.68 M
-$59.30 M-40.51%
31 December 2023
Summary:
Day One Biopharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$205.68 million, with the most recent change of -$59.30 million (-40.51%) on 31 December 2023. During the last 3 years, it has fallen by -$192.05 million (-1409.36%). DAWN annual EBITDA is now -1409.36% below its all-time high of -$13.63 million, reached on 31 December 2020.DAWN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$30.38 M
+$144.78 M+126.56%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently $30.38 million, with the most recent change of +$144.78 million (+126.56%) on 30 September 2024. Over the past year, it has increased by +$81.72 million (+159.18%). DAWN quarterly EBITDA is now -65.03% below its all-time high of $86.88 million, reached on 01 March 2019.DAWN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$210.08 M
+$81.72 M+28.01%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$210.08 million, with the most recent change of +$81.72 million (+28.01%) on 30 September 2024. Over the past year, it has dropped by -$21.25 million (-11.25%). DAWN TTM EBITDA is now -216.91% below its all-time high of $179.70 million, reached on 01 September 2019.DAWN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.5% | +159.2% | -11.3% |
| 3 y3 years | -1409.4% | +258.4% | -274.3% |
| 5 y5 years | - | -54.2% | -216.9% |
DAWN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1409.4% | at low | at high | +126.6% | -274.3% | +28.0% |
| 5 y | 5 years | -1409.4% | at low | -54.2% | +126.6% | -216.9% | +28.0% |
| alltime | all time | -1409.4% | at low | -65.0% | +126.6% | -216.9% | +28.0% |
Day One Biopharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $30.38 M(-126.6%) | -$210.08 M(-28.0%) |
| June 2024 | - | -$114.40 M(+71.6%) | -$291.80 M(+28.8%) |
| Mar 2024 | - | -$66.65 M(+12.2%) | -$226.57 M(+10.2%) |
| Dec 2023 | -$205.68 M(+40.5%) | -$59.41 M(+15.7%) | -$205.68 M(+8.9%) |
| Sept 2023 | - | -$51.34 M(+4.4%) | -$188.83 M(+6.7%) |
| June 2023 | - | -$49.16 M(+7.4%) | -$177.03 M(+7.6%) |
| Mar 2023 | - | -$45.77 M(+7.5%) | -$164.45 M(+12.3%) |
| Dec 2022 | -$146.38 M(+101.8%) | -$42.56 M(+7.7%) | -$146.38 M(+16.4%) |
| Sept 2022 | - | -$39.53 M(+8.1%) | -$125.71 M(+19.3%) |
| June 2022 | - | -$36.59 M(+32.1%) | -$105.36 M(+25.2%) |
| Mar 2022 | - | -$27.70 M(+26.5%) | -$84.16 M(+16.1%) |
| Dec 2021 | -$72.54 M | -$21.89 M(+14.1%) | -$72.51 M(+29.2%) |
| Sept 2021 | - | -$19.18 M(+24.7%) | -$56.12 M(+37.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$15.39 M(-4.0%) | -$40.73 M(+47.1%) |
| Mar 2021 | - | -$16.04 M(+190.9%) | -$27.69 M(+103.2%) |
| Dec 2020 | -$13.63 M(-8.6%) | -$5.51 M(+45.6%) | -$13.63 M(-185.2%) |
| Sept 2020 | - | -$3.79 M(+60.9%) | $16.00 M(-81.4%) |
| June 2020 | - | -$2.35 M(+19.1%) | $86.09 M(-5.1%) |
| Mar 2020 | - | -$1.98 M(-108.2%) | $90.75 M(-49.5%) |
| Dec 2019 | -$14.91 M | - | - |
| Dec 2019 | - | $24.11 M(-63.6%) | $179.60 M(-0.1%) |
| Sept 2019 | - | $66.31 M(+2780.5%) | $179.70 M(+10.2%) |
| June 2019 | - | $2.30 M(-97.4%) | $163.08 M(-6.0%) |
| Mar 2019 | - | $86.88 M(+258.8%) | $173.47 M(+100.3%) |
| Dec 2018 | - | $24.22 M(-51.3%) | $86.60 M(+38.8%) |
| Sept 2018 | - | $49.69 M(+291.3%) | $62.38 M(+391.3%) |
| June 2018 | - | $12.70 M | $12.70 M |
FAQ
- What is Day One Biopharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual EBITDA year-on-year change?
- What is Day One Biopharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly EBITDA year-on-year change?
- What is Day One Biopharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM EBITDA year-on-year change?
What is Day One Biopharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DAWN is -$205.68 M
What is the all time high annual EBITDA for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$13.63 M
What is Day One Biopharmaceuticals annual EBITDA year-on-year change?
Over the past year, DAWN annual earnings before interest, taxes, depreciation & amortization has changed by -$59.30 M (-40.51%)
What is Day One Biopharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DAWN is $30.38 M
What is the all time high quarterly EBITDA for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $86.88 M
What is Day One Biopharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, DAWN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$81.72 M (+159.18%)
What is Day One Biopharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DAWN is -$210.08 M
What is the all time high TTM EBITDA for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $179.70 M
What is Day One Biopharmaceuticals TTM EBITDA year-on-year change?
Over the past year, DAWN TTM earnings before interest, taxes, depreciation & amortization has changed by -$21.25 M (-11.25%)